Molecular epidemiology of Hepatitis C Virus (HCV) in liver disease patients in Sri Lanka

Abstract

Background: Globally, hepatitis C virus (HCV) is an important cause of chronic liver disease. Genotypes of HCV are associated with different profiles of pathogenicity, infectivity, and antiviral therapy. The prevalence of HCV and distribution of HCV genotypes in Sri Lanka in comparison with the rest of Asia is not well known.Objective: The objective of the study was to investigate the presence of HCV and to genotype HCV in a group of Sri Lankan patients suspected to have liver disease.Methods: A total of 1933 samples were screened for HCV antibodies using ELISA and HCV RNA with RT-PCR methods. RNA positive samples were genotyped by type specific amplification and by DNA sequencing.Results: Out Of the 1933 liver disease patients tested 219 (11.33%) were detected to be positive for anti-HCV antibodies, out of which, 54 (24.66%) were positive for HCV RNA. Furthermore out of 49 positively tested patients, 24 (48.97%) were found to be categorised as HCV genotype 1.Conclusion: This result confirms previous observations that the contribution of HCV as a causative virus in liver disease patients is low in Sri Lanka. HCV genotype 1 was found to be the most predominant genotype in studied cohort of Sri Lankan liver disease patients. DOI: http://dx.doi.org/10.3126/ajms.v6i3.10741Asian Journal of Medical Sciences Vol.6(3) 2015 1-5

Hepatitis C Virus Prevalence in Haemodialysis Patients From Three Centers in Baghdad, Iraq: A Survey By Polymerase Chain Reaction and Serological Methods

“…It is estimated that there are 170 million HCV-infected persons worldwide (Al Dhahry et al, 2003;and Senevirathna et al, 2008).The populations most affected by HCV are patients that undergo multiple blood transfusions, individuals who are intravenous and inhalant drug users, hemophiliacs, and haemodialysis patients (Alavian et al, 2011). HCV infection is a major health problem among dialysis patients in the developing countries.…”